Company’s Research Efforts Include 15 Poster Presentations; Strong Presence in Key Areas of Colorectal Research
IRVING, Texas, October 31, 2011 — Caris Diagnostics, a leading provider of expert anatomic pathology services, announced today upcoming highlights from the Company’s presentations at the American College of Gastroenterology (ACG) 2011 Annual Scientific Meeting being held in Washington, DC from October 29, 2011 to November 2, 2011. In total, Caris is presenting 15 abstracts. Specific highlights consist of new findings that build upon Caris’ strong emphasis in gastrointestinal disease research. Two examples are “High Prevalence of Celiac Disease in Women With Young Onset Collagenous Colitis” authored by Ahmed Bedeir, MD, Bhaskar Ganguly, and Mukunda Ray, MD, PhD and “Seasonal Patterns in Eosinophilic Esophagitis: An Analysis by Month of Diagnosis and Month of Birth” authored by Jennifer M. Hurrell, DO, Amnon Sonnenberg, MD, and Robert M. Genta, MD, FACG.
The first study found that young women with collagenous colitis are eight times more likely than the general population to have celiac disease. As a consequence of Dr. Bedeir’s finding (in the largest series of young patients with collagenous colitis ever reported), it would seem appropriate to recommend that women age 40 or younger who have a diagnosis of collagenous colitis also undergo an EGD with duodenal biopsies to exclude concurrent celiac disease. The second study showed that, contrary to previous suggestions derived from smaller series, there was no evidence of monthly or seasonal variation even within known regions with diverse climates among our 10,000 patients with eosinophilic esophagitis.
“The establishment of the Caris Research Institute as a structure for promoting and carrying out research has again generated a strong presence at the annual ACG meeting in Washington, D.C.,” Richard H. Lash, MD, Caris Diagnostics’ Chief Medical Officer, commented. “We are committed to leveraging our tremendous database and academic talent to answer important questions in the field of gastroenterology and are honored to have the opportunity to present our findings at ACG 2011.”
Full details on Caris Diagnostics’ 13 remaining posters include:
- “Reactive Gastropathy: A Nationwide Patho-epidemiologic Study in the United States.” Ismael Maguilnik, MD, Robert Genta, MD, FACG
- “Gastric Clear Cell Carcinoid Tumor in Patient with Von Hippel-Lindau Disease.” Ahmed Bedeir, MD, Baishali Bhattacharya, MD
- “Intestinal Spirochetosis in the United States: A Clinicopathologic Study of Colonic Biopsy Specimens.” M. H. Saboorian, MD, R. Shawn Kinsey, MD
- “Amoebic Colitis in the United States: A Patho-epidemiologic Study of Colonic Biopsy Specimens.”M. H. Saboorian, MD, Christopher J. Morgan, DO
- “Metastatic Breast Carcinoma to the Colon Mimicking Microscopic Colitis.” Baishali Bhattacharya, MD, Ahmed Bedeir, MD
- “Clinical and Pathologic Characteristics of Patients with a Diagnosis of Intestinal Metaplasia in Biopsies of the Gastroesophageal Junction.” Maria McIntire, MD
- “Advanced Colonic Adenomas and Colorectal Cancer Share Similar Dynamic Distribution Patterns.” Qinghua Yang, MD, Shou-jiang Tang,MD, Ruonan Wu, MS, Juliana Yang, MD
- “Herpes Esophagitis: A Clinicopathologic Study of Esophageal Specimens.” M. H. Saboorian, MD, Guy M. Lindberg, MD
- “Helicobacter pylori Gastritis is Inversely Correlated to Dysplasia in Patients with Barrett’s Esophagus.” Robert L. Trapasso, MD, Robert Genta, MD, FACG
- “Signet-ring Carcinoma in Gastric Biopsies: Expecting the Unexpected.” Christopher P. Golembeski, M.D., Robert Genta, MD, FACG
- “Autoimmune Enteropathy in Adults: A Clinicopathologic Study of Four Patients.” Richard Shawn Kinsey MD, Reenu Malhotra MD, Jay Gates MD
- “Dynamic Shift in the Distribution of Colorectal Cancer,” which will be co-presented by Qinghua Yang, MD, Shou-jiang Tang, MD, Ruonan Wu, MS, Juliana Yang, MD
- “Diagnostic Yield of the Colonic Biopsy in the Investigation of Diarrhea.” Christopher P. Golembeski, M.D., Robert Genta, MD, FACG
About Miraca Life Sciences (formerly Caris Diagnostics)
Miraca Life Sciences specializes in the development and commercialization of the highest quality anatomic pathology services, primarily in the fields of dermatopathology, hematopathology, gastrointestinal pathology and urologic pathology. The company’s core team of more than 70 world-leading, academic-caliber specialists utilize state of the art pathology laboratories currently headquartered in Irving, TX and throughout the United States to serve more than 3,000 patients every day. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Miraca Life Sciences continuously improves diagnostic precision.
Perry Street Communications